Company overview
Verder Scientific provides high-tech laboratory equipment for sample preparation, elemental analysis, materialography, hardness testing, particle characterization, heat treatment, and pharmaceutical testing. Their solutions support quality control, R&D, and analysis in life sciences and pharma labs worldwide. As part of the Verder Group, they operate through six manufacturing companies with global sales organizations and centers of excellence in Germany, USA, Japan, and France.
Verder Scientific - Enabling Progress is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include verder scientific, laboratory equipment, sample preparation, pharmaceutical testing, elemental analysis, particle characterization.
Products and technologies associated with Verder Scientific - Enabling Progress include Equipment — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.verder-scientific.com
- Markets served
- United States & Americas
- Keywords
- verder scientific, laboratory equipment, sample preparation, pharmaceutical testing, elemental analysis, particle characterization
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What laboratory equipment does Verder Scientific offer for pharmaceutical testing?
- Verder Scientific offers equipment for milling & sieving, particle characterization, and pharmaceutical testing, supporting sample preparation and analysis for quality control and R&D in pharma applications.
- What are Verder Scientific's key capabilities in life sciences R&D?
- Key capabilities include precise sample preparation, elemental analysis (O/N/H, C/S), materialography, hardness testing, heat treatment up to 1800°C, and IoT platforms for virtual labs, diagnostics, and automation.
- Where does Verder Scientific operate and provide support?
- Headquartered in Haan, Germany, with 13 sales organizations worldwide and centers of excellence in Germany, USA, Japan, and France, serving global laboratories.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
